# Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients

> **NCT01652664** · PHASE3 · COMPLETED · sponsor: **Alcon Research** · enrollment: 184 (actual)

## Conditions studied

- Pediatric Glaucoma
- Elevated IOP in Pediatric Patients
- Ocular Hypertension in Pediatric Patients

## Interventions

- **DRUG:** Travoprost 0.004% PQ ophthalmic solution
- **DRUG:** Timolol, 0.5% or 0.25% ophthalmic solution
- **DRUG:** Travoprost Vehicle

## Key facts

- **NCT ID:** NCT01652664
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 184 (ACTUAL)
- **Last updated:** 2015-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01652664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01652664, "Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01652664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*